[ad_1]
This “Heart Failure-Epidemiological Forecast-2030” Report has been added to ResearchAndMarkets.com provide.
This “Heart Failure (HF)-Epidemiological Forecast in 2030” report has an in-depth understanding of the United States, EU5 (Germany, France, Italy, Spain and the United Kingdom) and Japan.
Epidemiological view of heart failure (HF)
The epidemiology of the diseases covered in the report provides historical and predicted epidemiology, according to the total HF epidemic population, the diagnosed HF epidemic population, the HF epidemic cases diagnosed by gender, the HF epidemic cases diagnosed by age, and the NYHA category Classification of epidemiology. Among the 7 mm cases that cover the United States, EU5 countries (Germany, France, Italy, Spain and the United Kingdom), epidemic cases of HF were diagnosed, epidemic cases of HF diagnosed as ejection fraction, and those diagnosed as comorbidities The prevalence of HF cases is from 2018 to 2030.
Detailed epidemiological breakdown of heart failure
-
By 2020, the total confirmed prevalence of 7mm heart failure (HF) will be 12,602,028, which is expected to increase during the study period (2018-2030).
-
Among 7MM, the United States has the highest diagnosis rate of HF, that is, 5,163,119 cases in 2020, accounting for 40.97% of the total number of 7MM HF diagnoses.
-
Among the five EU countries, Germany has the most confirmed cases with 2,216,497 cases, followed by Spain with 1,283,827 cases and Italy with 1,164,031 cases. In 2020, the UK has the least number of cases at 728,547.
-
There are several comorbidities associated with heart failure, including obesity, hyperlipidemia, and metabolic syndrome. In the United States, by 2020, 3,837,746, 2,237,179, 991,319, 1,626,382, 1,587,659, 3,097,871 and 2,065,247 cases will be observed in hypertension, diabetes, chronic kidney disease, atrial fibrillation, COPD, ischemic heart disease and dilated cardiomyopathy by 2020 Case.
-
Age-specific data show that among elderly patients (≥85 years old), the most prevalent cases are diagnosed due to the gradual aging of the population and the survival rate after heart damage (such as myocardial infarction), especially after a developed heart attack For the sake of improving and better country.
-
Heart failure is an important cause of morbidity and death in women, and patients often develop when they are older. According to analysis, in the United States, by 2020, the estimated HF cases will be 2,478,297 males and 2,684,822 females.
Report scope
-
The report covers a descriptive overview of HF and explains its causes, symptoms, pathophysiology and genetic basis.
-
The report provides insights into the 7MM historical and predicted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
-
The report assessed the risk and burden of the disease and highlighted the unmet needs of HF.
-
The report helps to identify the growth opportunities of 7MM relative to the patient population.
-
The report breaks down the epidemiology of 7MM according to heart failure epidemic population, confirmed heart failure epidemic population, gender-specific heart failure epidemic cases, age-specific heart failure epidemic cases, and NYHA specific types of heart failure epidemic cases. Epidemic cases of heart failure diagnosed with ejection fraction, and epidemic cases of heart failure diagnosed with comorbidities.
Highlights of the report
-
HF’s 10-year forecast
-
7MM coverage
-
Total HF
-
Confirmed cases of HF
-
Gender case of HF
-
Age-specific cases of HF
-
The diagnostic prevalence of NYHA specific categories of HF
-
Ejection fraction diagnosed as an epidemic case of heart failure
-
Epidemic cases related to diagnosed heart failure and comorbidities
Key question to answer
-
What are the disease risks and burdens of HF?
-
What is the history of HF patients in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan?
-
At the 7MM level, what is the predicted number of patients with HF?
-
Within 7 mm, what are the opportunities for growth in the patient population associated with HF?
-
Among the above-mentioned countries, which country has the highest prevalence of HF in the forecast period (2021-2030)?
-
During the forecast period (2021-2030), at what CAGR is the estimated population of 7MM to grow?
Reasons to buy
-
Formulate business strategies by understanding trend shaping and driving 7MM HF epidemiological forecasts.
-
The HF epidemiological report and model were written and developed by Masters and Ph.D. First-level epidemiologist.
-
The HF epidemiology model developed by the publisher is easy to navigate, interact with the dashboard and epidemiology based on a transparent and consistent methodology. In addition, the model supports the data provided in the report and uses reputable data sources to show disease trends during the 10-year forecast period.
Critical assessment
-
Patient breakdown
-
Disease risk and burden
-
Segmented disease risk
-
Factors driving the growth of specific patient groups
For more information about this report, please visit https://www.researchandmarkets.com/r/10vvvq
View the source code version on businesswire.com: https://www.businesswire.com/news/home/20210517005459/zh/
[ad_2]
Source link
